1973Ä꣬Ñо¿ÈËÔ±ÔÚÒ»ÖÖº±¼ûµÄÖ¬ÖÊ´úлÎÉÂÒ(³ÆΪ¼Ò×åÐԸߵ¨¹Ì´¼ÑªÖ¢IIIÐÍ)»¼Õߵļ«µÍÃܶÈÖ¬ÂÑ°×(VLDL)Öз¢ÏÖÁËÒ»ÖÖ¸»º¬¾«°±ËáµÄÂÑ°×Öʱ»ÃüÃûΪÔØÖ¬ÂÑ°×E(APOE,Apolipoprotein E)¡£Ô½À´Ô½¶àµÄÑо¿·¢ÏÖAPOEÔÚÖ¬ÖÊ´úл¡¢ÐÄѪ¹Ü¼²²¡(CVD)ºÍ°¢¶û´Äº£Ä¬²¡(AD)Öз¢»ÓÖØÒª×÷Óá£
ͼƬÀ´Ô´£ºgenetrace
ʲôÊÇAPOE£¿
APOE»ùÒòλÓÚ19ºÅȾɫÌå,±àÂëÔØÖ¬ÂÑ°×E(APOE),ÊÇѪ½¬ÖÐÖØÒªµÄÔØÖ¬ÂÑ°×Ö®—¡£¸ÃÂÑ°×¼ÓÈë»úÌåѪ֬µ÷ÖΡ¢µ¨¹Ì´¼Æ½ºâ¡¢ÖÐÊàÉñ¾ÏµÍ³ÊÜËðÉñ¾ÔªµÄÐÞ¸´,¾ßÓÐÖØÒªÉúÀíѧ¹¦Ð§¡£
APOE»ùÒòµÄ½á¹¹ºÍ¹¦Ð§
APOE»ùÒò°üÂÞËĸöÍâÏÔ×ÓºÍÈý¸öÄÚº¬×Ó£¬±àÂëÒ»¸öÓÉ299¸ö°±»ùËá×é³ÉµÄÂÑ°×ÖÊ£¬Ô¼34 kDa¡£Ö¬ÂÑ°×EÊÇÒ»ÖÖÔØÖ¬ÂÑ°×£¬Ö÷Òª´æÔÚÓÚѪ½¬ÖеÄÖ¬ÂѰ׿ÅÁ£ÖУ¬È缫µÍÃܶÈÖ¬ÂÑ°×£¨VLDL£©¡¢µÍÃܶÈÖ¬ÂÑ°×£¨LDL£©ºÍ¸ßÃܶÈÖ¬ÂÑ°×£¨HDL£©¡£Ö¬ÂÑ°×E¼ÓÈëÖ¬ÖʵÄÔËÊäºÍ´úл£¬µ÷Öε¨¹Ì´¼ºÍ¸ÊÓÍÈýõ¥µÄˮƽ¡£
APOE»ùÒòµÄ¶à̬ÐÔ
APOE»ùÒòÓÐ2¸öSNPλµãrs429358ºÍrs7412×é³É3ÖÖÏà¶Ô³£¼ûµ¥±¶ÐÍε2¡¢ε3¡¢ε4,Ï໥×éºÏÐγÉ6ÖÖÖ÷Òª»ùÒòÐÍε2ε2¡¢ε2ε3¡¢ε3ε3¡¢ε2ε4¡¢ε3ε4¡¢ε4ε4×é³ÉÈýÖÖÒì¹¹Ìå (APOE E2¡¢E3¡¢E4)¡£ÕâЩµÈλ»ùÒò±àÂëµÄÖ¬ÂÑ°×EÔڽṹÉÏÂÔÓвîÒ죬µ¼ÖÂÆäÔÚ¹¦Ð§ºÍ´úлÉϵIJîÒì¡£
Ö÷ÒªÇø±ðÊÇÆäDNAÐòÁÐÉÏÊöÁ½¸öλµãµÄ¼î»ù²îÒì,Ôì³ÉËüÃÇËù±àÂëµÄÂÑ°×ÔÚµÚ112λºÍµÚ158λµÄ°±»ùËá²Ð»ù·¢ÉúÁ˱仯¡£APOE2ÔÚÁ½¸öλµãÉϾùΪ°ëë×°±Ëá (Cys)£¬APOE3ÔÚµÚ112λΪ°ëë×°±Ëá,¶øµÚ158λΪ¾«°±Ëá (Arg)£¬APOE4ÔÚÁ½¸öλµãÉϾùΪ¾«°±Ëá¡£ÆäÖÐE4ÐÍ»áÔö¼Ó°¢¶û´Äº£Ä¬²¡¡¢Â·Ò×Ìå³Õ´ôµÄ·¢²¡·çÏÕ£¬Í¬Ê±Ò²»áʹѪ½¬µ¨¹Ì´¼ºÍµÍÃܶÈÖ¬ÂÑ°×µÄˮƽÉý¸ß£¬´Ó¶øÔö¼ÓÐÄÄÔѪ¹Ü¼²²¡µÄ·¢²¡·çÏÕ¡£
APOE»ùÒòµÄ¶à̬ÐÔÓë¶àÖÖ¼²²¡µÄ¹Øϵ
£¨1£©Ó붯ÂöÖàÑùÓ²»¯
Ѫ½¬ÖÐѪ֬Èç¹û¹ý¶àÈÝÒ×Ôì³É“Ѫ³í”£¬ÔÚѪ¹Ü±ÚÉϳÁ»ý,Öð½¥ÐγÉС°ß¿é¡£ÓÉÓÚ¹ý¶àÖ¬·¾³Á»ý,Ôì³É¶¯ÂöÓ²»¯ ʹѪÁ÷ÊÜ×è,×èÈûѪҺÁ÷ÈëÏàÓ¦²¿Î»,ÒýÆð¹¦Ð§È±Ëð,·¢ÉúÔÚ¹Ú×´¶¯Âöʱ¿ÉÒýÆð¹ÚÐIJ¡,·¢ÉúÔÚÄÔѪ¹ÜʱÒ×·¢ÉúÄÔ¹£ËÀ¡£Ð¯´øAPOE ε2µÈλ»ùÒòÕß,¶Ô¶¯ÂöÖàÑùÓ²»¯ÓзÀ»¤×÷Ó᣶øЯ´øAPOE ε4µÈλ»ùÒòÕß,µ¨¹Ì´¼¼°¸ÊÓÍÈýõ¥º¬Á¿¸ß,ÊǶ¯ÂöÖàÑùÓ²»¯µÄDZÔÚΣÏÕÒòËØ¡£
£¨2£©Óë°¢¶û´Äº£Ä¬²¡
°¢¶û´Äº£Ä¬²¡ (ÀÏÄê³Õ´ôÖ¢)ÊÇ—ÖÖÉñ¾ÍËÐÐÐÔ¼²²¡,·ÖΪÔç·¢Ðͺͳٷ¢ÐÍ,ÆäÖгٷ¢ÐͽÏΪ³£¼û¡£¶øAPOE ε4µÈλ»ùÒòÓë³Ù·¢ÐÍ·çÏÕÓйء£´óÁ¿ÑªÖ¬ÔÚÄÔ²¿³Á»ý,Ó°ÏìÄÔµ¨¹Ì´¼ÎÈ̬,µ¼ÖÂϸ°ûÍâÉñ¾Ñ×ÐÔ°ß¿éºÍϸ°ûÄÚÉñ¾ÔªÏËά²øÈÆ,Ôö¼Ó°¢¶û´Äº£Ä¬²¡µÄ»¼²¡·çÏÕ¡£
·çÏÕÐÍ»ùÒòÈËȺµÄ°¢¶û´Äº£Ä¬²¡·¢Éú·çÏÕ¿É´ïÆÕͨÈËȺµÄ10±¶ÒÔÉÏ¡£Òò´Ë¿ÉÒÔͨ¹ýAPOE»ùÒò¼ì²âÀ´¼ì²ì×Ô¼ºÊÇ·ñΪ·çÏÕÐÍ,¶Ô¿É¿ØµÄΣÏÕÒòËؽøÐÐÔçÆÚ¸ÉÔ¤,50%ÒÔÉϵÄAPOE ε4»ùÒòЯ´øÕß²»»áÉú³¤³É°¢¶û´Äº£Ä¬²¡¡£
£¨3£©ÔØÖ¬ÂÑ°×EÓëËûÍ¡ÀàÒ©Îï
ËûÍ¡ÀàÒ©ÎïÊÇÄ¿Ç°Ó¦ÓÃ×î¹ã·ºµÄ½µÖ¬Ò©ÎïÖ®—£¬ÄÜÓÐЧ·ÀÖÎÐÄÄÔѪ¹Ü¼²²¡µÄ·¢Éú¡£²»½öÄÜǿЧµØ½µµÍ×ܵ¨¹Ì´¼(TC)ºÍµÍÃܶÈÖ¬ÂÑ°×(LDL)£¬¶øÇÒÄÜ—¶¨Ë®Æ½ÉϽµµÍ¸ÊÓÍÈýõ¥(TG)£¬Éý¸ß¸ßÃܶÈÖ¬ÂÑ°×(HDL)¡£
Ñо¿Ö¤Êµ£¬ËûÍ¡ÀàÒ©Îï½µÖ¬ÖÎÁÆЧ¹ûÓëAPOE»ùÒò¶à̬ÐÔÓйء£APOE3ÐÍЯ´øÕßʹÓÃËûÍ¡ÀàÒ©ÎïÁÆЧÕý³£¡£¶øÁíÍâÁ½ÖÖ±äÒìÐÍ£¬APOE2ÐÍЯ´øÕßʹÓÃËûÍ¡ÀàÒ©ÎïÁÆЧ½ÏºÃ£¬APOE4ÐÍЯ´øÕßʹÓÃËûÍ¡ÀàÒ©ÎïÁÆЧÍùÍù²»¼Ñ¡£
ÔØÖ¬ÂÑ°×E£¨APOE£©»ùÒò¼ì²â
¼ì²âÒâÒ壺APOE»ùÒò¼ì²â½á¹û·´Ó³µÄÊÇÓëÂÑ°×¹¦Ð§ÃÜÇÐÏà¹ØµÄÐÄÄÔѪ¹Ü¼²²¡µÄ»¼²¡·çÏÕ¡¢ËûÍ¡ÀàÓÃÒ©½¨Òé¡£ÐÄÄÔѪ¹Üϵͳ¼²²¡»¼²¡·çÏÕͬʱÊÜ»·¾³¡¢Òûʳ¡¢Ô˶¯µÈ¶àÖÖÒòËØÓ°Ï죬¶ø¶ÔÒ©ÎïÁÆЧµÄÔ¤²âÒ²»áÊÜ»·¾³¡¢Òûʳ¡¢ÉúÀí²¡Àí×´¿ö¼°ºÏ²¢ÓÃÒ©µÈÅÓ´óÇé¿öµÄ×ÌÈÅ¡£Æ¾¾Ý¼ì²â½á¹û¶¨ÖÆÔ¤·À½¨Ò飬»ý¼«½øÐн¡¿µ¹ÜÀí£¬¾¡ÔçÔ¤·À£¬¼°Ê±¸ÉÔ¤¡£
¼ì²âÒªÁ죺 PCR
²Î¿¼ÎÄÏ×
[1] wang QY, wang wJ, wu L, et al. Meta- analysis of ApOE ε2/ ε3/ ε4 polymorphism and cerebral infarction[J]. Journal of Neural Transmission, 2013, 120(10):1479-1489.
[2] zhang M, Gu w, Qiao S, et al. Apolipoprotein E Gene polymorphism and Risk for coronary Heart Disease in the chinese population: A Meta- Analysis of 61 Studies lncluding 6634 cases and 6393 controls[J]. Journal of the American college of cardiology, 2014, 9(4):e95463.
[3] Liu M, Bian c, zhang J, et al. Apolipoprotein E gene polymorphism and Alzheimer,s disease in chinese population: a meta-analysis[J]. Scienti?c Reports, 2013, 4(4):4383.
[4] Thompson JF, Hyde cL, wood LS, paciga SA, Hinds DA, cox DR, Hovingh GK, Kastelein JJ. comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort. circ cardiovasc Genet. 2009 Apr;2(2):173-81.
[5] Courtney M, Kloske,Michael E, Belloy,Elizabeth E, Blue et al. Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference.[J] .Alzheimers Dement, 2024, 0: 0.
ÔÁ¹«Íø°²±¸ 44030602000441ºÅ